Who invested in Osivax

3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$39Mraised across 3 rounds since 2019, from 3 sources

$9.0MSeries A$11MSeries B$20MGrant

Latest round: Grant, $20MAug 2025
Step-upi: 1.9×
Investors: 6 (1 led)

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202020212022202320242025

$9.0MSeries A$11MSeries B$20MGrant

First round: Series A, $9.0M
Biggest round: $20M
Usual gap between rounds: 5.7 years

The rounds

Aug 2025
Grant$20M1 new2 returning
Source recorded
Mar 2025
Series B$11M3 new
Source recorded
Jul 2019
Series A$9.0M2 new
- NoshaqLead
- Anaxago
Reported by FinSMEs

Founders and team

From Osivax's own website: 1 founder, 5 on the team.

Alexandre Le VertExecutive Chairman & Co-Founder

Linda LebonChief Regulatory Officer
Vincent MonchoisChief Manufacturing Officer
Charlotte PrimardHead of Non-Clinical Immunology
Florian SourdVP Finance
Frédéric CrenMember of the Board of Directors

AdvisersDr. Otfried KistnerDr. Tim MosmannProf. Arnold Monto

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2019Series B2025Grant2025

National Institute of Allergy and Infectious Diseases

Anaxago

Everyone who backed them

BpifranceGovernment2rounds

EIC AcceleratorGovernment2rounds

NoshaqVC firm1round, led 1

CapHorn InvestVC firm1round

National Institute of Allergy and Infectious DiseasesInvestment firm1round

AnaxagoVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Osivax

Who invested in Osivax?

Osivax's investors include Bpifrance, EIC Accelerator, Noshaq, CapHorn Invest and National Institute of Allergy and Infectious Diseases, and 1 more on record.